Randomized pilot study assessing the safety and tolerability hyperthermic intraperitoneal chemotherapy (HIPEC) at completion of interval cytoreductive surgery or chemotherapy the day prior to interval cytoreductive surgery for patients with stage III/IV ovarian cancer undergoing neoadjuvant chemotherapy
Backes, Floor Jenniskens, Calo, Corinne, Chambers, Laura
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Differences in self-reported health-related quality of life in heterosexual and sexual minority women surviving cancer: 2013 to 2018 national health interview survey
Hutchcraft, Megan Leigh Gleason, Patterson, Joanne G, Teferra, Andreas A, Montemorano, Lauren, Backes, Floor Jenniskens
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
A randomized phase II study comparing single-agent olaparib, single-agent cediranib, and the combinations of cediranib/olaparib, olaparib/durvalumab (MEDI4736), cediranib/durvalumab (MEDI4736), and olaparib/AZD5363 (capivasertib) in women with recurrent, persistent, or metastatic endometrial cancer
Rimel, B.J., Bender, David, Enserro, Danielle, Westin, Shannon Neville, Richardson, Debra L., Holman, Laura L., Alluri, Nitya, Stuckey, Ashley, Garg, Ruchi, Gill, Sarah, Tanner, Edward, Leath, Charles A., Backes, Floor Jenniskens, Fleury, Aimee, Mackay, Helen
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Use of Khorana score to predict VTE in patients undergoing chemotherapy for uterine cancer
Wagner, Vincent, Levine, Monica, Piver, Rachael, Backes, Floor Jenniskens, Cohn, David E., Copeland, Larry J., Cosgrove, Casey, Fowler, Jeffery, O'Malley, David M., Bixel, Kristin Leigh
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012
Mackay, Helen, Nixon, Andrew B., Enserro, Danielle, Bender, David, Rimel, BJ, Powell, Matthew A., Richardson, Debra L., Holman, Laura L., Alluri, Nitya, Mathews, Cara Amanda, Garg, Ruchi, Gill, Sarah, Matei, Daniela, Leath, Charles A., Backes, Floor Jenniskens, Fleury, Aimee, Swisher, Elizabeth M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
KEYNOTE-C93/GOG-3064/ENGOT-en15: A phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma
Slomovitz, Brian M., Cibula, David, Simsek, Tayup, Mirza, Mansoor Raza, Maćkowiak-Matejczk, Beata, Hudson, Emma, Romero, Ignacio, Colombo, Nicoletta, Korach, Jacob, Yin, Rutie, Gilbert, Lucy, Hasegawa, Kosei, Tyulyandina, Alexandra, Baron-Hay, Sally E., Willmott, Lyndsay, Backes, Floor Jenniskens, Orlowski, Robert J., Zhou, Xuan, Khemka, Vivek, Pignata, Sandro
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Efficacy and safety of lucitanib + nivolumab in patients with advanced gynecologic malignancies: Phase 2 results from the LIO-1 study (NCT04042116; ENGOT-GYN3/AGO/LIO)
Patel, Manish R., Makker, Vicky, Oaknin, Ana, Pignata, Sandro, Backes, Floor Jenniskens, Gonzalez Martin, Antonio, Eskander, Ramez Nassef, Pothuri, Bhavana, Richardson, Debra L., Secord, Angeles Alvarez, Van Nieuwenhuysen, Els, Liu, Joyce F., Musa, Fernanda, Penson, Richard T., Wride, Kenton, Lepley, Denise M., Dusek, Rachel, Cameron, Teresa, Hamilton, Erika P., Concin, Nicole
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
LIO-1: Lucitanib + nivolumab in patients with advanced solid tumors—Updated phase 1b results and initial experience in phase 2 ovarian cancer cohort
Hamilton, Erika P., Jackson, Camille Catherine, Eskander, Ramez Nassef, Backes, Floor Jenniskens, Makker, Vicky, Musa, Fernanda, Olawaiye, Alexander, Alldredge, Jill, Pothuri, Bhavana, Secord, Angeles Alvarez, Concin, Nicole, Gonzalez Martin, Antonio, Go, Jowell, Wride, Kenton, Lepley, Denise M., Cameron, Teresa, Patel, Manish R.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer
Lheureux, Stephanie, Matei, Daniela, Konstantinopoulos, Panagiotis A., Block, Matthew Stephen, Jewell, Andrea, Gaillard, Stephanie, McHale, Michael S., McCourt, Carolyn K, Temkin, Sarah, Girda, Eugenia, Backes, Floor Jenniskens, Werner, Theresa Louise, Duska, Linda R., Kehoe, Siobhan Marie, Wang, Lisa, Wildman, Rachel, Wang, Ben X, Ohashi, Pamela S, Wright, John Joseph, Fleming, Gini F.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Characterization and predictors of long term (≥ 10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer patients
Friedlander, Michael, Chan, John K., Java, Jim, Armstrong, Deborah K, Markman, Maurie, Herzog, Thomas J., Monk, Bradley J., Backes, Floor Jenniskens, Secord, Angeles Alvarez, Bonebrake, Albert J., Rose, Peter Graham, Tewari, Krishnansu Sujata, Mannel, Robert S., Lentz, Samuel S., Geller, Melissa Ann, Copeland, Larry J.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article